Deal Timeline

Plotted by close date where disclosed, otherwise announcement. Select any marker to jump to the deal entry.

The Rationale That Repeats.

Three patterns show up across DuPont de Nemours's deal book — what the team buys, how it pays, and how it integrates. The patterns are the throughline; the deals below are the evidence.

01
Acquisition criteria
Buy capabilities, not size.
Since the 2019 split, DuPont has been highly selective — three acquisitions in five years, each a defined capability rather than a sprawling platform. Laird PM brought electromagnetic shielding and thermal management; Spectrum and Donatelle brought medical-device manufacturing. Management framed each as adding to DuPont's industrial technologies growth pillar and strengthening positions in stable and fast-growing end-markets.
Laird Performance MaterialsSpectrum Plastics GroupDonatelle Plastics
02
Capital deployment
Stack the same end-market twice.
DuPont built its medical-device platform through back-to-back deals: Spectrum Plastics Group in 2023, then Donatelle Plastics in 2024 — explicitly described by management as the second acquisition that will deepen its expertise in the medical device market segments. Both fold into Industrial Solutions within Electronics & Industrial alongside the existing Liveo healthcare offerings, concentrating M&A on a single high-growth therapeutic-manufacturing theme.
Laird Performance MaterialsSpectrum Plastics GroupDonatelle Plastics
03
Integration approach
Acquire while reshaping the portfolio — and walk away when the math fails.
DuPont's deals ran in parallel with major divestitures (the Nutrition & Biosciences Reverse Morris Trust to IFF, the Mobility & Materials sale to Celanese, and the planned electronics and water separations). The same discipline showed on the buy side: DuPont terminated its agreed acquisition of Rogers Corporation on November 1, 2022 when regulatory clearance could not be obtained in time, paying a $162.5 million termination fee rather than extending an uncertain deal.
Laird Performance MaterialsSpectrum Plastics GroupDonatelle Plastics

The Full Deal Book

3 acquisitions. Each entry carries the deal value, financing structure, target revenue, executive commentary, and the original SEC filing — the evidence behind the patterns above.

01 Laird Performance Materials · Global — 11 manufacturing sites across North America, Europe and Asia $2,404M
Announced Mar 2021 Closed Jul 2021 all cash
electromagnetic shieldingthermal management solutionsperformance components for electronic devices

Acquired from Advent International, Laird Performance Materials is a world leader in high-performance electromagnetic shielding and thermal management solutions, with 11 manufacturing sites across North America, Europe and Asia and approximately $465 million of 2020 revenue. DuPont integrated Laird PM into the Interconnect Solutions business within the Electronics & Industrial segment to strengthen its position in advanced electronics applications. The FY21 10-K records net assets (consideration for Laird PM) of $2,404 million. $2,404 million net consideration (announced at approximately $2.3 billion).

Why it was attractive
  • Adds high-margin electromagnetic-shielding and thermal-management content directly into DuPont's electronics-materials platform
  • with exposure to secular growth in 5G
  • advanced electronics and electrification
The acquisition of Laird Performance Materials is a significant step in advancing DuPont's strategy to grow as a global innovation leader and premier multi-industrial company.Ed Breen — Executive Chairman and CEO, DuPont
Laird Performance Materials is an outstanding business. DuPont will be an excellent partner for Laird Performance Materials.Shonnel Malani — Managing Director, Advent International
02 Spectrum Plastics Group · United States (Atlanta, GA) and international markets $1.75B
Announced May 2023 Closed Aug 2023 all cash
medical-device componentsflexible packaging productsplastic and silicone extrusionsprecision manufacturing for medicalindustrial and food sectors

Acquired from private-equity owner AEA Investors, Spectrum Plastics Group is a leading manufacturer of critical components and devices primarily for medical end-markets requiring highly complex, mission-critical applications. Spectrum manufactures flexible packaging products, plastic and silicone extrusions, and components for the industrial, food and medical business sectors across the United States and international markets. It became part of Industrial Solutions within the Electronics & Industrial segment. The FY24 10-K records a net purchase price of approximately $1,781 million, including a net upward adjustment of approximately $43 million for acquired cash and net working capital. Approximately $1.75 billion (net purchase price of approximately $1,781 million per FY24 10-K).

Why it was attractive
  • Expands DuPont's exposure to stable
  • fast-growing medical and healthcare end-markets and complements its existing medical-related products
  • serving a broad base of leading medical-technology OEMs
Today we also announced a definitive agreement to acquire Spectrum Plastics Group, a leading manufacturer of critical components and devices primarily into medical end-markets for highly complex, mission critical applications. This intended acquisition adds to DuPont's industrial technologies growth pillar and strengthens our existing position in stable and fast-growing healthcare end-markets.Ed Breen — Executive Chairman and CEO, DuPont
03 Donatelle Plastics · New Brighton, Minnesota, United States $365M
Announced Jun 2024 Closed Jul 2024 all cash plus contingent earn-out
medical-device injection moldingliquid silicone rubber processingprecision machiningdevice assemblytool building

Donatelle Plastics, LLC is a medical-device company specializing in the design, development and manufacture of medical components and devices, headquartered in New Brighton, Minnesota. DuPont integrated it into Industrial Solutions within the Electronics & Industrial segment, alongside its existing healthcare offerings including Spectrum and Liveo. The FY24 10-K records a net purchase price of $365 million, which includes the estimated fair value of a $40 million contingent earn-out liability. $365 million net purchase price (including a contingent earn-out liability with an estimated fair value of $40 million).

Why it was attractive
  • A second medical-device contract manufacturer that deepens DuPont's expertise in medical-device market segments and builds scale in healthcare alongside Spectrum and Liveo
Donatelle Plastics Incorporated will be the second acquisition that will deepen our expertise in the medical device market segments.Jon Kemp — President, DuPont Electronics & Industrial
We're excited for this next chapter in Donatelle's journey and for our team to join DuPont.Treasa Springett — President, Donatelle Plastics

More Acquirer Playbooks

See how VectorShift works for your firm

Request Demo